Mark joined the European Vaccine Initiative (EVI) in January 2011 as Project Manager for primarily the European Commission FP7 funded TRANSVAC project, but also other EVI core projects.
Until joining EVI Mark was a vaccine scientist at Nobilon International in The Netherlands. He was responsible for the CMC development of several viral vaccines (e.g. influenza, Chikungunya) including preclinical research, analytics, GMP vaccine production & release, documentation, CMC/regulatory affairs.
Between 1995 – 2000 Mark obtained a M.Sc. in Medical Biology from Vrije Universiteit, Amsterdam followed by a Ph.D in HIV immunology and virology in 2006 from the Academic Medical Centre, Amsterdam. Mark has (co-)authored several technical dossiers for clinical trial applications and scientific articles in peer reviewed journals.